Medeor Therapeutics is a private, late clinical stage, biotechnology company dedicated to the discovery, development, and commercialization of transformative and personalized cellular immunotherapies.
Total raised: $57M
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnova.... |
| 14.09.2021 | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 27.11.2017 | Series B | $57M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 28.11.2017 | Term Sheet... | THREE THINGS Good morning, Te... | - | - | fortune.co... |
| 28.11.2017 | Medeor The... | - | Portfolio ... | - | sofinnova.... |
| 27.11.2017 | Medeor The... | Medeor Therapeutics, Inc., a S... | USA | - | finsmes.co... |